Company intelligence / Profile preview

International Biotechnology Trust

London, England, United Kingdomschroders.com ↗

Ownership: Private
Development stage: Other

Overview

International Biotechnology Trust provides investors with exposure to the global biotechnology sector by investing in a diversified portfolio of quoted and unquoted biotech and life science companies. The trust focuses on innovative firms addressing high unmet medical needs and aims for long-term capital growth while also providing income through dividends. Its managers emphasize risk management and have outperformed relevant indices over multiple timeframes.

Therapeutic areas: PsychiatryOncologyRare Diseases
Modalities: Small moleculeMonoclonal antibodyGene therapyRNA therapy
Industry: Investors

Partnerships

Portfolio includes venture funds managed by SV Health Investors/SV Health Managers LLP as AIFM

Beyond the preview

Go deeper on International Biotechnology Trust.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Biotechnology Trust.

Explore the full profile